Hashtag
The Times Real Estate

Application for clinical trial of AIM Vaccine’s human diploid rabies vaccine

An iterative process is highly effective in increasing the value of large items

HONG KONG SAR - Media OutReach Newswire - 8 November 2024 - AIM Vaccine (06660.HK), the world's second largest supplier of rabies vaccines, announced on 7th November that the application for clinical trial of the iterative-process highly-effective human diploid rabies vaccine developed by the Company has been submitted to the Center for Drug Evaluation (CDE) of National Medical Products Administration of China recently.


According to the announcement, the i iterative-process highly-effective human diploid rabies vaccine developed by AIM Vaccine shows an iterative upgrade compared to the traditional human diploid rabies vaccines of the first generation in many aspects.

The iterative-process highly-effective human diploid rabies vaccine developed by the Company has taken the lead in breaking through the technical bottlenecks of low virus titer and low yield in the traditional process. It has been optimized and innovated in the purification process with the product quality and safety significantly improved.

Compared with the number of traditional rabies vaccinations, this product developed by the Group can be vaccinated with either "five-needle approach", "simple four-needle approach" or "2-1-1 four-needle approach", which is more flexible and convenient.

There are two kinds of rabies vaccines, namely the serum-containing rabies vaccine and the serum-free rabies vaccine. However, no serum-free rabies vaccine has been registered or marketed yet. The mainstream Vero cell rabies vaccine and human diploid rabies vaccine currently available in the market are serum-containing rabies vaccines.

Compared with the traditional Vero cell rabies vaccines, human diploid rabies vaccine uses human diploid cells instead of Vero cells, which are homologous to humans and have a natural safety advantage. The human diploid rabies vaccine currently available in the market is 3 to 5 times more expensive than the Vero cell rabies vaccine, with higher product added value.

According to the announcement, AIM Vaccine has completed the construction of an iterative-process high-efficiency human diploid rabies vaccine workshop that meets international standards, and has completed the production of commercial-scale Phase III clinical trial samples, which is capable of producing this product in large scale.

China is the world's largest rabies vaccine market. According to the 2024 interim performance report of AIM Vaccine, the approved lot release volume of China's rabies vaccines increased from 58.80 million in 2019 to 78.50 million in 2021, representing an increase of 33.6%. It is expected that the market scale will increase to RMB22.0 billion by 2030, partially due to the iteration of rabies vaccine products upgrade. With the expansion of the pet market and the popularization of pre-exposure immunity knowledge, it is expected that the demand for human rabies vaccines will continue to grow in the future.
Hashtag: #AIM

The issuer is solely responsible for the content of this announcement.

Business News

BFSI Security Summit 2025 to Address Rising Cybersecurity Threats in Africa’s Financial Sector

JOHANNESBURG, SOUTH AFRICA - Media OutReach Newswire - 1 April 2025 - The BFSI Security Summit 2025 is set to take place on May 7, 2025, at the Radisson Blu Gautrain, Sandton, Johannesburg, bringin...

Hashtag.net.au - avatar Hashtag.net.au

SonicWall’s Zero Trust Network Access (ZTNA) Solutions Driving Success Tackling 2025’s Biggest Cybersecurity Challenges

One Year After Acquiring Banyan Security, SonicWall’s Cloud Secure Edge/ZTNA Remote Access Solutions See Remarkable Growth SINGAPORE - Media OutReach Newswire - 1 April 2025 - SonicWall today marks a...

Hashtag.net.au - avatar Hashtag.net.au

Prudential partners Thomson Medical Centre to offer more healthcare options and convenience for customers

SINGAPORE - Media OutReach Newswire - 1 April 2025 - Prudential Singapore ("Prudential") and Thomson Medical Centre (TMC) have signed a partnership agreement to enhance the healthcare experience for ...

Hashtag.net.au - avatar Hashtag.net.au

VT Markets Releases Q2 Report On U.S. Dollar Dominance Shift as Central Bank Diverge

HONG KONG SAR - Media OutReach Newswire – 1 April 2025 - Leading global financial services provider VT Markets today releases its Q2 report, highlighting the season's key market developments and pote...

Hashtag.net.au - avatar Hashtag.net.au

JINGDONG Logistics Expands Middle East Presence with 5 Warehouses, Offering Premium Services Across MENA Markets

RIYADH, SAUDI ARABIA - Media OutReach Newswire - 1 April 2025 - Recently, at JINGDONG Logistics' warehouse in Riyadh, goods were being efficiently processed, destined not only for Middle East co...

Hashtag.net.au - avatar Hashtag.net.au

Record-breaking Global Participation: Final Call to Join the TERA-Award by 9 April

HONG KONG SAR - Media OutReach Newswire – 1 April 2025 - The 4th TERA-Award Smart Energy Innovation Competition, organised by The Hong Kong and China Gas Company Limited (Towngas) and empowered by Fu...

Hashtag.net.au - avatar Hashtag.net.au

Health & Wellness

The Importance of Having a Defibrillator in Public Spaces

Hashtag.net.au - avatar Hashtag.net.au

Life is uncertain! It is almost impossible to be 100% sure of the future, anything can happen to anyone at any time. However, in the case of Sudden Cardiac Arrests (SCA), the presence of an Automat...

Understanding Anxiety: Different Types and Treatment Options

Hashtag.net.au - avatar Hashtag.net.au

(Source) Every person experiences anxiety in some form as they face either pre-event heart palpitations before important events or constant sleep deprivation because of ongoing concerns. People exp...

How Technology Is Improving Community Support Services?

Hashtag.net.au - avatar Hashtag.net.au

(Source) Technology is literally a part of our everyday lives. Everything we do is highly dependent on technology in this day and age. The interesting part is that not just the younger generations ...